One of the most pressing issues facing pharmaceutical companies is keeping up with the torrent of ever-increasing regulatory requirements covering virtually every aspect of their business: clinical trials, data protection, data exclusivity, vigilance, personalised medicine and companion diagnostics, cell therapies, reimbursement, tenders, interactions with HCPs and PMCPA compliance to discussing products in development prior to marketing authorisation.

We help clients develop strategies and implement compliance systems to manage these requirements.

Unsurprising regulators are struggling to cope with these changes and we also help clients challenge decisions by regulators.